CMV herpesvirus can also trigger high blood pressure

A herpesviruses, which affect a significant portion of the population, have primarily been known for their infectious diseases so far. However, recent research suggests that these viruses can also cause more serious health problems, such as the development of high blood pressure. These discoveries may open a new dimension in the treatment and prevention of hypertension.

During the research, scientists noticed that herpesviruses, particularly cytomegalovirus (CMV), cause inflammation in blood vessels, which can lead to high blood pressure in the long term. The presence of CMV in the bodies of a significant portion of adults indicates that it appears not only as an infectious disease but also as a serious cardiovascular risk factor.

This new knowledge warns that it would be wise to consider the role of viruses in the prevention of cardiovascular diseases. Continuing research is essential to understand the connections between viruses and high blood pressure and to develop more effective treatment methods.

The relationship between herpesviruses and high blood pressure

Herpesviruses, including cytomegalovirus (CMV), are present in a significant portion of the population without causing any symptoms. However, recent studies show that these viruses trigger inflammation in blood vessels, which may contribute to the development of high blood pressure. The presence of CMV can be detected in 60-99% of the adult population, which is concerning given the global problem of high blood pressure.

Researchers used mice in their experiments and observed that the presence of CMV was associated with an increase in blood pressure. The inflammation caused by the virus not only affects blood pressure but may also contribute to the development of other serious diseases, such as heart and kidney diseases. This discovery could open new perspectives in the treatment of hypertension and may offer new methods for prevention.

It is important to emphasize that research related to viruses is ongoing, and the goal is to better understand the connections between viruses and vascular problems. With this information, future treatments may be more targeted and effective.

New treatment options for hypertension

The discoveries made by scientists not only bring new insights into the relationship between herpesviruses and high blood pressure but also raise new treatment possibilities. Currently, traditional medications used to treat high blood pressure, such as ACE inhibitors and other antihypertensive agents, are widely used. However, based on the latest research, it is conceivable that antiviral drugs and vaccines could provide a new direction for the treatment of hypertension.

Clyde Crumpacker, a researcher at Harvard University, emphasized that the primary goal of the research is to understand the persistent presence and effects of viruses in the bloodstream. The use of antiviral medications for the treatment of high blood pressure offers a new possibility that has not been widely recognized until now. Currently, several pharmaceutical companies are working on developing vaccines specifically targeting herpesviruses, thereby reducing the risk of high blood pressure.

The aim of future research is to confirm the relationship between viruses and high blood pressure and to identify effective treatment methods that can improve patients’ quality of life by integrating antiviral therapies. Experts believe this approach could offer new opportunities for the prevention of high blood pressure and cardiovascular diseases, thus contributing to the improvement of public health.